Sandoz launches first generic Remodulin in the U.S.

Sandoz launched in the U.S. the first generic version of pulmonary arterial hypertension (PAH) drug Remodulin treprostinil from United Therapeutics.

The Novartis AG (NYSE:NVS; SIX:NOVN) unit said its generic has 180 days of marketing exclusivity...